Brain Glioma

• CLINICAL_TRIALS research · 2026-03-04
  Clinical Trial Update: Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors [NA]

  Emory University is conducting a pediatric brain tumor trial to assess metabolic changes during spectroscopic MRI-guided proton therapy in m…

• CLINICAL_TRIALS trial_result · 2026-01-29
  Clinical Trial Update: Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas [Phase 3]

  Phase 3 clinical trial evaluating Elucirem for DSC-MRI perfusion in brain gliomas has completed and results have been posted.

• CLINICAL_TRIALS research · 2025-08-19
  Clinical Trial Update: Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating QH104 cell injections for malignant brain gliomas, including glioblastoma multiforme and other high-gr…

• CLINICAL_TRIALS trial_result · 2025-06-03
  Clinical Trial Update: The Effects of Mild Sedation on Motor Function Networks in Patients With Brian Gliomas [NA]

  This completed clinical trial investigated the effects of mild sedation using midazolam and dexmedetomidine on motor function networks in pa…

• CLINICAL_TRIALS trial_result · 2025-05-11
  Clinical Trial Update: Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently

  This completed clinical trial evaluated functional MRI for mapping language areas in bilingual patients with glioma to aid pre-surgical plan…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2024-12-24
  Clinical Trial Update: Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain [NA]

  Bevacizumab is being studied as neoadjuvant therapy for new high-grade gliomas in the brain; the trial is currently recruiting.

• CLINICAL_TRIALS trial_result · 2022-01-10
  Clinical Trial Update: 18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety [Phase 3]

  Phase 3 clinical trial evaluating 18F-DOPA PET imaging for biodistribution and safety.